Scientific exploration

Foundations & references

Clinical foundations, methodological comparisons, explanatory hypotheses and responses to scientific objections.

Foundations

Clinical and neurofunctional foundations

DMOKA® draws on current knowledge in psychotraumatology, stress neurophysiology and integrative therapies. Its clinical framework rests on the observation that trauma is stored multimodally — sensory, emotional, cognitive and somatic — and that its reprocessing benefits from equally multimodal stimulation.

The method's neurofunctional foundations integrate research on procedural memory, memory reconsolidation, the role of the autonomic nervous system in stress regulation, and Stephen Porges' polyvagal theory.

Comparison

DMOKA®, EMDR & IMO

DMOKA® shares with EMDR and IMO (Integration through Eye Movements) the use of eye movements as a therapeutic lever. However, it differs in several structural respects.

EMDRStandardised 8-phase protocol, centred on bilateral eye movements and SUD-scale desensitisation. Validated by HAS and WHO for PTSD treatment.
IMOUse of specific eye movement patterns to access sensory memories and recode traumatic experience. More sensory approach, less protocolised than EMDR.
DMOKA®Integrative approach combining eye movements, kinaesthetic, auditory, vocal stimulations (including SVL) and cognitive reprogramming in a unified process. Designed for simple and complex trauma.

Comparative synthesis

Where EMDR relies on a standardised bilateral stimulation protocol, and IMO explores specific eye patterns with sensory aims, DMOKA® offers simultaneous multimodal integration. The patient's voice, rhythm, structured touch and the somato-vibro-logo-sensory dimension (TLEi®) form a coherent clinical whole that goes beyond eye movements alone.

Hypotheses

Current explanatory hypotheses

As with EMDR, the exact mechanisms of DMOKA® are not the subject of definitive scientific consensus. Several hypotheses are being explored:

Memory reconsolidation — Multimodal stimulation during target memory reactivation may facilitate a modified reconsolidation process, allowing the memory to be re-stored with a reduced emotional charge.

Autonomic nervous system regulation — The combination of kinaesthetic, vocal and ocular stimulations may promote the shift from a state of sympathetic activation (fight/flight) towards an optimal tolerance window.

Vibratory and informational hypothesis — This more exploratory hypothesis concerns the TLEi® dimension of the method. It does not claim the status of a validated theory, but guides ongoing clinical research.

Rigour

Scientific objections & cautious responses

DMOKA®, like any integrative clinical method, is subject to legitimate questions. We take these objections seriously and respond with due caution.

DMOKA® does not currently have published randomised controlled trials in peer-reviewed journals. Its validation rests on clinical data accumulated since 2005, feedback from trained practitioners, and a theoretical framework drawing on mechanisms shared with better-documented approaches (EMDR, sensorimotor therapies). The method's rigour comes through structured training and mandatory supervision.
This term, used in some historical texts, does not refer to quantum physics in the academic sense. It refers to an exploratory hypothesis about vibratory and informational processes. DMOKA® does not claim validation from fundamental physics and favours an integrative clinical positioning.
DMOKA® is not a variation of EMDR. Although it shares the use of eye movements, its process integrates dimensions absent from standard EMDR: the patient's voice as a regulatory tool, structured kinaesthetic stimulations, the TLEi® dimension and an approach specifically designed for complex trauma.
Yes. DMOKA® is designed as an integrative method that can fit within a broader therapeutic framework. Many trained practitioners use it alongside verbal psychotherapy, body-based approaches, sophrology or clinical hypnosis.

Frequently asked questions

Scientific FAQ

Answers to the most common questions about the scientific and clinical positioning of DMOKA®.

DMOKA® draws on mechanisms shared with approaches whose neuroscientific foundations are better documented (EMDR, sensorimotor therapies). Memory reconsolidation and autonomic nervous system regulation hypotheses are supported by the scientific literature, but their specific application to DMOKA® has not yet been the subject of dedicated controlled studies.
DMOKA® is not currently listed in official health authority recommendations (HAS, WHO). It is practised within a regulated private training framework, with supervision and ethical requirements. Transparency on this point is part of the method's commitment to rigour.
DMOKA® is neither a hypnotic nor a sophrological technique. It relies on active multimodal stimulations (ocular, kinaesthetic, auditory) targeting the reprocessing of specific traumatic memories. The patient's state of consciousness remains active and oriented. Some trained practitioners do, however, use it alongside these other approaches.
SVL stands for "somato-vibro-logo-sensory stimulation". It is a component of the revised DMOKA® version that integrates voice, rhythm and body vibrations into the desensitisation process. This dimension is exploratory and subject to ongoing clinical research.

Resources

Documents to download

The documents below explore the clinical and theoretical foundations of DMOKA®. They are intended for professionals wishing to assess the method before committing to training.

PDF

Clinical foundations of DMOKA®

Presentation of the clinical and neurofunctional foundations of the method, including the theoretical framework and proposed mechanisms of action.

PDFDocument forthcoming

PDF

Comparison DMOKA® / EMDR / IMO

Detailed comparative analysis of the three approaches: commonalities, structural differences, respective indications and DMOKA® specificities.

PDFDocument forthcoming

PDF

Scientific hypotheses and research directions

Overview of explanatory hypotheses (memory reconsolidation, autonomic regulation, TLEi® dimension) and clinical research perspectives.

PDFDocument forthcoming

PDF

Detailed training programme 2026

Content of the 3 modules of 3 days, optional module 4, teaching methods, target audience and certification arrangements.

PDFDocument forthcoming

Some documents are being finalised. Contact us to obtain current versions.

Go further

You have read the foundations. Now discover the training content or the next available sessions.

Training programmeSessions 2026
Book